Loading…
Operates in Pharma — Retail - Pharmacy. Per the activity note to the FY2024 annual report, the company carries out retail trade in pharmaceutical products.
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 4,004 | 6,309 | 7,013 | 7,395 | 5,096 | 4,955 | 4,660 | +2.6% |
| Total COGS | 1,739 | 2,764 | 2,741 | 4,138 | 3,186 | 1,993 | 1,737 | -0.0% |
| Gross Profit | 2,265 | 3,545 | 4,272 | 3,257 | 1,910 | 2,961 | 2,923 | +4.3% |
| Gross Margin | 56.6% | 56.2% | 60.9% | 44.0% | 37.5% | 59.8% | 62.7% | |
| 856 | 1,404 | 2,728 | 3,058 | 1,183 | 2,571 | 3,223 | +24.7% | |
| EBITDA | 1,409 | 2,141 | 1,544 | 199 | 727 | 391 | 300 | nmf |
| EBITDA Margin | 35.2% | 33.9% | 22.0% | 2.7% | 14.3% | 7.9% | 6.4% | |
| Total D&A | 8 | 25 | 33 | 131 | 41 | 66 | 47 | +35.8% |
| EBIT / Operating Income | 1,401 | 2,116 | 1,511 | 68 | 686 | 325 | 347 | nmf |
| Total Interest Expense | 0 | 0 | 104 | 46 | 35 | 27 | 32 | -25.9% |
| 0 | 1 | 232 | 190 | 189 | 342 | 406 | nmf | |
| Profit Before Tax | 1,401 | 2,117 | 1,638 | 168 | 841 | 639 | 28 | -48.1% |
| Total Income Tax | 0 | 0 | 0 | 310 | 21 | 29 | 0 | -69.2% |
| Net Profit / (Loss) | 1,401 | 2,117 | 1,603 | 330 | 873 | 701 | 28 | -48.1% |
| Net Margin | 35.0% | 33.6% | 22.9% | 4.5% | 17.1% | 14.2% | 0.6% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →